The Journal of Organic Chemistry
ARTICLE
(26.0 mg), 94% ee]. Enantiomeric purity was determined by HPLC
analysis [Daicel Chiralpak AD-H, hexane/2-propanol = 50:1, flow rate =
0.5 mL/min, retention time 33.4 min (major) and 38.0 min (minor)].
1H NMR (400 MHz, CDCl3) δ 7.39 (2H, m), 6.37 (1H, m), 5.51 (1H, d,
J = 8.0 Hz), 5.29 (1H, br s), 1.47 (9H, s), 1.46 (9H, s); 13C NMR (100
MHz, CDCl3) δ 165.1, 154.8, 143.7, 139.6, 124.7, 109.1, 81.9, 80.3, 60.7,
44.7, 28.34, 28.29; IR (neat) 3350, 2978, 2093, 1690, 1506, 1368, 1252,
1163 cmꢀ1; HRMS (ESI) exact mass calcd for C16H23N3O5 m/z
N-Boc imine (0.10 mmol, 21.9 mg) and tolyl (diazomethyl)sulfone (0.15
mmol, 29.4 mg). The crude material was purified by column chromatog-
raphy on silica gel (eluted with toluene/EtOAc = 60:1) to give the title
compound [60% (25.1 mg), 90% ee]. Enantiomeric purity was deter-
mined by HPLC analysis [Daicel Chiralpak AD-H, hexane/2-propanol =
10:1, flow rate = 0.5 mL/min, retention time 35.0 min (minor), 40.0 min
(major)]. 1H NMR (400 MHz, CDCl3) δ 7.55 (2H, d, J = 8.4 Hz), 7.23
(2H, d, J = 8.4 Hz), 7.16 (1H, dd, J = 8.0, 7.6 Hz), 7.04 (1H, d, J = 7.6 Hz),
6.98 (1H, d, J= 8.0Hz), 6.90(1H, s), 5.70 (1H, d, J =8.0Hz), 5.30 (1H, br
s), 2.42 (3H, s), 2.23 (3H, s), 1.41 (9H, s); 13C NMR (100 MHz, CDCl3)
δ 154.5, 144.1, 140.0, 138.6, 136.8, 129.7, 128.9, 128.8, 126.9, 126.8, 123.2,
80.5, 70.9, 52.0, 28.2, 21.6, 21.3; IR (neat) 2085, 1710, 1495, 1367, 1327,
1244, 1147, 1088 cmꢀ1; HRMS (ESI) exact mass calcd for C21H25N3O4S
360.1530 ([M + Na]+), found m/z 360.1533 ([M + Na]+); [R]2D8
+23.7 (c = 1.0, CHCl3, 94% ee).
=
Dimethyl (R)-2-(tert-Butoxycarbonylamino)-1-diazo-2-[3,4-(meth-
ylenedioxy)phenyl]ethylphosphonate (13f). Prepared according to the
general procedure with (3,4-methylenedioxy)benzaldehyde N-Boc
imine (0.10 mmol, 24.9 mg) and dimethyl (diazomethyl)phosphonate
(0.15 mmol, 22.5 mg). The crude material was purified by column
chromatography on silica gel (eluted with hexane/ethyl acetate = 1:1) to
give the title compound as a yellow oil [64% yield (25.7 mg), 91% ee].
Enantiomeric purity was determined by HPLC analysis [Daicel Chiralcel
OD-H, hexane/2-propanol = 10:1, flow rate = 0.5 mL/min, retention
m/z 438.1458 ([M + Na]+), found m/z 438.1461 ([M + Na]+); [R]2D9
+19.0 (c = 1.0, CHCl3, 90% ee).
=
Tolyl (R)-2-(tert-Butoxycarbonylamino)-1-diazo-2-(4-tolyl)ethylsulfone
(15c). Prepared according to the general procedure with 4-tolualdehyde
N-Boc imine (0.10 mmol, 21.9 mg) and tolyl (diazomethyl)sulfone
(0.15 mmol, 29.4 mg). The crude material was purified by column
chromatography on silica gel (eluted with toluene/EtOAc = 60:1) to
give the title compound [61% (25.4 mg), 94% ee]. Enantiomeric purity
was determined by HPLC analysis [Daicel Chiralpak AD-H, hexane/
2-propanol = 10:1, flow rate = 0.5 mL/min, retention time 34.1 min
(minor), 40.9 min (major)]. 1H NMR (400 MHz, CDCl3) δ 7.59 (2H,
d, J = 8.0 Hz), 7.24 (2H, d, J = 8.0 Hz), 7.07ꢀ7.03 (4H, m), 5.69 (1H, d,
1
time 16.8 min (minor) and 20.0 min (major)]. H NMR (400 MHz,
CDCl3) δ 6.86ꢀ6.78 (3H, m), 5.97 (2H, s), 5.37 (2H, br s), 3.76 [3H, d,
2J(1H, 31P) = 11.8 Hz], 3.68 [3H, d, 2J(1H, 31P) = 11.8 Hz], 1.45 (9H, s);
13C NMR (100 MHz, CDCl3) δ 154.6, 148.1, 147.4, 133.0 [d, 3J(13C,
31P) = 3.3 Hz], 119.6, 108.4, 106.9, 101.3, 80.3, 53.1 [d, 2J(13C, 31P) =
5.7 Hz], 51.8, 46.0 [d, 1J(13C, 31P) = 229.4 Hz], 28.2; IR (neat) 3287,
2980, 2091, 1709, 1489, 1244, 1167, 1024 cmꢀ1; HRMS (ESI) exact
mass calcd for C16H22N3O7P m/z 422.1088 ([M + Na]+), found m/z
422.1092 ([M + Na]+); [R]D26 = +55.7 (c = 1.0, CHCl3, 91% ee).
Dimethyl (R)-2-(tert-Butoxycarbonylamino)-1-diazo-2-(3-furyl)-
ethylphosphonate (13h). Prepared according to the general procedure
with 3-furaldehyde N-Boc imine (0.10 mmol, 19.5 mg) and dimethyl
(diazomethyl)phosphonate (0.15 mmol, 22.5 mg). The crude material
was purified by column chromatography on silica gel (eluted with
hexane/ethyl acetate = 1:1) to give the title compound as a yellow oil
[78% yield (27.1 mg), 91% ee]. Enantiomeric purity was determined by
HPLC analysis [Daicel Chiralcel OJ-H, hexane/2-propanol = 20:1, flow
rate = 0.5 mL/min, retention time 24.8 min (minor) and 30.7 min
(major)]. 1H NMR (400 MHz, CDCl3) δ 7.45ꢀ7.41 (2H, m), 6.41 (1H,
s), 5.40 (1H, m), 5.31 (1H, br s), 3.77 [3H, d, 2J(1H, 31P) = 11.8 Hz],
3.73 [3H, d, 2J(1H, 31P) = 11.6 Hz], 1.46 (9H, s); 13C NMR (100 MHz,
CDCl3) δ 154.7, 143.9, 139.8, 124.4 [d, 3J(13C, 31P) = 3.3 Hz], 109.0,
80.3, 53.1 [d, 2J(13C, 31P) = 5.7 Hz], 53.0 [d, 2J(13C, 31P) = 4.9 Hz], 45.5,
J = 8.0 Hz), 5.29 (1H, br s), 2.42 (3H, s), 2.30 (3H, s), 1.40 (9H, s); 13
C
NMR (100 MHz, CDCl3) δ 154.5, 144.1, 139.9, 138.0, 134.0, 129.7,
129.5, 126.8, 126.0, 80.4, 70.9, 51.8, 28.2, 21.6, 21.0; IR (neat) 2085,
1711, 1510, 1327, 1165, 1149, 1087 cmꢀ1; HRMS (ESI) exact mass
calcd for C21H25N3O4S m/z 438.1458 ([M + Na]+), found m/z
438.1462 ([M + Na]+); [R]D28 = +28.9 (c = 1.0, CHCl3, 94% ee).
Tolyl (R)-2-(tert-Butoxycarbonylamino)-1-diazo-2-(2-naphthyl)ethyl-
sulfone (15d). Prepared according to the general procedure with
2-naphthaldehyde N-Boc imine (0.10 mmol, 25.5 mg) and tolyl
(diazomethyl)sulfone (0.15 mmol, 29.4 mg). The crude material was
purified by column chromatography on silica gel (eluted with toluene/
EtOAc = 50:1) to give the title compound [77% (34.6 mg), 93% ee].
Enantiomeric purity was determined by HPLC analysis [Daicel Chir-
alpak AD-H, hexane/2-propanol = 10:1, flow rate = 1.0 mL/min,
1
retention time 20.0 min (minor), 24.7 min (major)]. H NMR (400
MHz, CDCl3) δ 7.76 (1H, m), 7.72ꢀ7.68 (2H, m), 7.61 (1H, s), 7.52ꢀ
7.44 (4H, m), 7.18 (1H, dd, J = 8.8, 1.6 Hz), 7.06 (2H, d, J = 8.0 Hz), 5.91
(1H, d, J = 6.8 Hz), 5.54 (1H, br s), 2.32 (3H, s), 1.43 (9H, s); 13C NMR
(100 MHz, CDCl3) δ 154.6, 144.1, 139.8, 134.1, 133.0, 132.9, 129.6,
128.8, 128.0, 127.5, 126.7, 126.44, 126.42, 125.2, 123.9, 80.6, 70.8, 52.2,
28.2, 21.4; IR (neat) 2360, 2340, 2083, 1710, 1495, 1368, 1323, 1306,
1244, 1146 cmꢀ1; HRMS (ESI) exact mass calcd for C24H25N3O4S m/z
1
45.4 [d, J(13C, 31P) = 230.2 Hz], 28.2; IR (neat) 3273, 2978, 2091,
1709, 1524, 1524, 1248, 1165, 1024 cmꢀ1; HRMS (ESI) exact mass
calcd for C13H20N3O6P m/z 368.0982 ([M + Na]+), found m/z
368.0983 ([M + Na]+); [R]D23 = +67.1 (c = 1.0, CHCl3, 91% ee).
Tolyl (R)-2-(tert-Butoxycarbonylamino)-1-diazo-2-phenylethylsulfone
(15a). Prepared according to the general procedure with benzaldehyde
N-Boc imine (0.10 mmol, 20.5 mg) and tolyl (diazomethyl)sulfone
(0.15 mmol, 29.4 mg). The crude material was purified by column
chromatography on silica gel (eluted with toluene/EtOAc = 60:1) to
give the title compound [70% (28.1 mg), 92% ee]. Enantiomeric purity
was determined by HPLC analysis [Daicel Chiralpak AD-H, hexane/
2-propanol = 10:1, flow rate = 0.5 mL/min, retention time 43.1 min
(minor), 48.6 min (major)]. 1H NMR (400 MHz, CDCl3) δ 7.57 (2H,
d, J = 8.4 Hz), 7.29ꢀ7.21 (5H, m), 7.18 (2H, m), 5.73 (1H, d, J = 6.8
Hz), 5.35 (1H, br s), 2.41 (3H, s), 1.40 (9H, s); 13C NMR (100 MHz,
CDCl3) δ 154.5, 144.2, 139.9, 136.9, 129.8, 128.8, 128.2, 126.8, 126.1,
80.5, 70.9, 51.9, 28.2, 21.5; IR (neat) 2085, 1711, 1597, 1495, 1452,
1367, 1325, 1238, 1145, 1088 cmꢀ1; HRMS (ESI) exact mass calcd for
C20H23N3O4S m/z 424.1301 ([M + Na]+), found m/z 424.1301 ([M +
Na]+); [R]D30 = +9.7 (c = 1.0, CHCl3, 92% ee).
474.1458 ([M + Na]+), found m/z 474.1463 ([M + Na]+); [R]3D1
+26.2 (c = 1.0, CHCl3, 93% ee).
=
Tolyl (R)-2-(tert-Butoxycarbonylamino)-1-diazo-2-(4-chlorophe-
nyl)ethylsulfone (15e). Prepared according to the general procedure
with 4-chlorobenzaldehyde N-Boc imine (0.10 mmol, 24.0 mg) and tolyl
(diazomethyl)sulfone (0.15 mmol, 29.4 mg). The crude material was
purified by column chromatography on silica gel (eluted with toluene/
EtOAc = 60:1) to give the title compound [60% (25.3 mg), 90% ee].
Enantiomeric purity was determined by HPLC analysis [Daicel Chir-
alpak AD-H, hexane/2-propanol = 10:1, flow rate = 0.5 mL/min, reten-
tion time 29.7 min (minor), 35.8 min (major)]. 1H NMR (400 MHz,
CDCl3) δ 7.53 (2H, d, J = 8.4 Hz), 7.27ꢀ7.15 (4H, m), 7.09 (2H, d, J =
8.4 Hz), 5.70 (1H, d, J = 8.0 Hz), 5.40 (1H, br s), 2.43 (3H, s), 1.41 (9H,
s); 13C NMR (100 MHz, CDCl3) δ 154.5, 144.4, 139.8, 135.5, 134.1,
129.8, 128.9, 127.6, 126.7, 80.7, 70.6, 51.7, 28.2, 21.6; IR (neat) 2360,
2340, 2085, 1710, 1595, 1490, 1454, 1393, 1367, 1325, 1242,
1147 cmꢀ1; HRMS (ESI) exact mass calcd for C20H22ClN3O4S m/z
Tolyl (R)-2-(tert-Butoxycarbonylamino)-1-diazo-2-(3-tolyl)ethylsulfone
(15b). Prepared according to the general procedure with 3-tolualdehyde
6035
dx.doi.org/10.1021/jo2005999 |J. Org. Chem. 2011, 76, 6030–6037